AstraZeneca Plc revenue for the last year amounted to 54.07 B USD, the most of which — 19.85 B USD — came from its highest performing source at the moment, Oncology, the year earlier bringing 17.56 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought AstraZeneca Plc 21.35 B USD, and the year before that — 18.56 B USD.